Science Explorer Interactive view Map

NeuroGenetic Pharmaceuticals (United States)

Research works
40
▼ 37% vs 2013–17
Citations
2.2k
54.9 per fractional work
Top-10% rate
25.7%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: NeuroGenetic Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.49× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 20.66× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.36× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.20× its world share, 0 worksChemistryComputer Science: 0.66× its world share, 0 worksComputer ScienceEngineering: 0.25× its world share, 0 worksEngineeringHealth Professions: 0.22× its world share, 0 worksHealth ProfessionsMedicine: 1.50× its world share, 1 worksMedicineNursing: 2.60× its world share, 0 worksNursingDecision Sciences: 0.42× its world share, 0 worksDecision SciencesPsychology: 2.25× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Neuroscience, 20.7×. Every wedge is a field page.

Which keywords describe research at NeuroGenetic Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Crystal Structure, Genetic Variation, Pharmacology, Cell Signaling, Drug Discovery, Stress, Signal Transduction and Arrestin.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Crystal Structure6▲ 55×2 topics
  2. Genetic Variation5▲ 41×4 topics
  3. Cell Signaling5▲ 35×3 topics
  4. Pharmacology5▲ 36×2 topics
  5. Drug Discovery5▲ 29×4 topics
  6. Stress4▲ 26×4 topics
  7. Signal Transduction4▲ 41×2 topics
  8. Arrestin4▲ 124×1 topic
  9. G-Protein-Coupled Receptors4▲ 124×1 topic
  10. Serotonin4▲ 150×2 topics
  11. Prefrontal Cortex4▲ 68×3 topics
  12. Neural Plasticity4▲ 46×3 topics
  13. Dopamine4▲ 163×1 topic
  14. Reward Circuitry4▲ 163×1 topic
  15. Oxidative Stress3▲ 4.2×15 topics
  16. Alzheimer's Disease2▲ 23×5 topics
  17. Neurodegeneration2▲ 16×6 topics
  18. Pharmacokinetics2▲ 17×3 topics
  19. Gene Expression2▲ 7.2×7 topics
  20. Schizophrenia2▲ 32×3 topics
  21. Neurodegenerative Diseases2▲ 17×4 topics
  22. Neuronal Signaling2▲ 135×1 topic
  23. Nicotinic Acetylcholine Receptors2▲ 135×1 topic
  24. Deep Learning1▲ 1.68×3 topics
  25. Genomic Integration1▲ 34×2 topics
  26. Neurobiology1▲ 11×5 topics
  27. Anxiety1▲ 9.0×5 topics
  28. Cytochrome P4501▲ 44×1 topic
  29. Metabolism1▲ 5.1×6 topics
  30. Neuroinflammation1▲ 12×4 topics
  31. Pharmacogenetics1▲ 79×1 topic
  32. Biopharmaceutical Production1▲ 37×2 topics
  33. Depression1▲ 3.8×7 topics
  34. Genetic Modification1▲ 69×1 topic
  35. Genetics1▲ 3.6×6 topics
  36. Neurological Disorders1▲ 3.9×10 topics
  37. Transgenic Animals1▲ 69×1 topic
  38. Distributed Systems1▲ 10×1 topic
  39. Grid Computing1▲ 38×1 topic
  40. Toxicology1▲ 12×3 topics

Which research topics does NeuroGenetic Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Neurotransmitter Receptor Influence on Behavior, Neuroethics, Human Enhancement, Biomedical Innovations, Attention Deficit Hyperactivity Disorder and Advanced Memory and Neural Computing.

  1. 1 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
  2. 2 Neuroethics, Human Enhancement, Biomedical Innovations Cognitive Neuroscience 0 works
  3. 3 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
  4. 4 Advanced Memory and Neural Computing Electrical and Electronic Engineering 0 works
  5. 5 EEG and Brain-Computer Interfaces Cognitive Neuroscience 0 works
  6. 6 Neural dynamics and brain function Cognitive Neuroscience 0 works
  7. 7 Genetics and Neurodevelopmental Disorders Genetics 0 works
  8. 8 Topic Modeling Artificial Intelligence 0 works
  9. 9 CRISPR and Genetic Engineering Molecular Biology 0 works
  10. 10 Machine Learning in Healthcare Artificial Intelligence 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.5%not open60.5%

World: 28% of research is openly available.

with international co-authors32.2%domestic only67.8%

World: 19% is written across borders.

How has NeuroGenetic Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 37% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rancho Santa Fe

All research institutions in Rancho Santa Fe

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.